Adjuvant Radiotherapy in Breast Cancer: Consideration of Cost-Benefits in Relation to the CRC (King's/Cambridge) Trial
- 1 July 1989
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 5 (3) , 415-422
- https://doi.org/10.1017/s0266462300007479
Abstract
The Cancer Research Campaign (CRC) Trial demonstrates a decreased incidence of local recurrence for patients randomized to prophylactic radiotherapy following mastectomy. Irradiated patients alive after 5 years, however, have a small increased risk of dying from causes other than breast cancer. How to estimate the cost-benefit of such therapy is discussed.Keywords
This publication has 3 references indexed in Scilit:
- A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.Journal of Clinical Oncology, 1986
- The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy dataThe British Journal of Radiology, 1984
- The cancer research campaign (King's/Cambridge trial for early breast cancer: Clinico-pathological aspectsBritish Journal of Cancer, 1982